We used ApoE−/− mice, a widely used model of human atherosclerosis, and exposed them to a high dose (6 Gy), which is relevant to cancer therapy, or to a moderate dose (0.3 Gy), such as might occur in high-dose diagnostic procedures or worst-case scenario occupational exposures (e.g., nuclear workers). Here, APOE is linked to cancer.